Antithrombin III Deficiency
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Antithrombin III Deficiency
|
1.000 |
Biomarker
|
disease |
HPO |
|
|
|
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
CLINVAR |
"CpG dinucleotides are ""hotspots"" for mutation in the antithrombin III gene. Twelve variants identified using the polymerase chain reaction."
|
2615648 |
1989 |
Antithrombin III Deficiency
|
1.000 |
Biomarker
|
disease |
BEFREE |
SERPINC1 was sequenced in 214 cases with a positive test for antithrombin deficiency, including 67 with no deficiency in the sample delivered to our laboratory.
|
27098529 |
2016 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
SERPINC1 gene mutations in antithrombin deficiency.
|
28317092 |
2017 |
Antithrombin III Deficiency
|
1.000 |
Biomarker
|
disease |
BEFREE |
Antithrombin III microheterogeneity in antithrombin III deficiency and in the antithrombin III abnormality, "antithrombin III Toyama".
|
3116713 |
1987 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
CLINVAR |
A heparin binding site Arg79Cys missense mutation in the SERPINC1 gene in a Korean patient with hereditary antithrombin deficiency.
|
21325262 |
2011 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
A novel splice-site mutation c.42-2A>T (IVS1-2A>T) of SERPINC1 in a Korean family with inherited antithrombin deficiency.
|
21885952 |
2011 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
A recurrent deletion in the antithrombin gene, AT106-108(-6 bp), identified by DNA heteroduplex detection.
|
8486379 |
1993 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
A series of 10 Polish patients with thromboembolic events and antithrombin deficiency: two new c.1154-1 G>C and c.1219-534 A>G SERPINC1 gene splicing mutations.
|
31157679 |
2019 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
A small deletion in SERPINC1 causes type I antithrombin deficiency by promoting endoplasmic reticulum stress.
|
27708219 |
2016 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Antithrombin 'DREUX' (Lys 114Glu): a variant with complete loss of heparin affinity.
|
12353073 |
2002 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Antithrombin Budapest 3. An antithrombin variant with reduced heparin affinity resulting from the substitution L99F.
|
1555650 |
1992 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Antithrombin Cambridge II, 384 Ala to Ser. Further evidence of the role of the reactive centre loop in the inhibitory function of the serpins.
|
1906811 |
1991 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Antithrombin Chicago, amino acid substitution of arginine 393 to histidine.
|
2781509 |
1989 |
Antithrombin III Deficiency
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Antithrombin III Basel. Identification of a Pro-Leu substitution in a hereditary abnormal antithrombin with impaired heparin cofactor activity.
|
3080419 |
1986 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Antithrombin III Basel. Identification of a Pro-Leu substitution in a hereditary abnormal antithrombin with impaired heparin cofactor activity.
|
3080419 |
1986 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Antithrombin III Kumamoto II; a single mutation at Arg393-His increased the affinity of antithrombin III for heparin.
|
7832187 |
1995 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Antithrombin III Nagasaki (Ser116-Pro): a heterozygous variant with defective heparin binding associated with thrombosis.
|
8443391 |
1993 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
CLINVAR |
Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability.
|
6582486 |
1984 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability.
|
6582486 |
1984 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Antithrombin III Utah: proline-407 to leucine mutation in a highly conserved region near the inhibitor reactive site.
|
3191114 |
1988 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Antithrombin Morioka (Cys 95-Arg): a novel missense mutation causing type I antithrombin deficiency.
|
9157604 |
1997 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Antithrombin mutation database: 2nd (1997) update. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.
|
9031473 |
1997 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Antithrombin Phe229Leu: a new homozygous variant leading to spontaneous antithrombin polymerization in vivo associated with severe childhood thrombosis.
|
12595305 |
2003 |